Intraoperative Imaging of Thoracic Malignancies With Indocyanine Green
Our specific aim is to determine if Indocyanine Green (ICG) administered intraoperatively and imaged using our camera will aid in the identification of a suspected lung nodule.
Checked against the public recordLast updated Feb 5, 2018 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Other
- Study type
- Interventional
- Phase
- Phase 1
- Sponsor
- University of Pennsylvania
- Interventions being studied
- Drug: Indocyanine Green
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: 1. Adult patients over 18 years of age 2. Patients presenting with a lung nodule or mass presumed to be resectable stage I, II, or IIIa non-small call lung cancer on pre-operative assessment 3. Good operative candidate as determined by a thoracic oncology multidisciplinary team 4. Subject capable of giving informed consent and participating in the process of consent Exclusion Criteria: 1. Pregnant women as determined by urinary or serum beta hCG within 72 hours of surgery 2. Subjects with a history of iodide allergies 3. At-risk patient populations * Homeless patients * Patients with drug or alcohol dependence * Children and neonates * Patients unable to participate in the consent process
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of PennsylvaniaPhiladelphia, Pennsylvania
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 5, 2018. Always confirm current availability with the study team.